This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Kips Bay Medical, Inc. Fourth-Quarter And Full-Year 2012 Results Conference Call

Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (NASDAQ:KIPS), announced today that Kips Bay will release fourth-quarter and full-year ended December 31, 2012, results on Thursday, March 28, 2013, at market close and will hold a conference call to discuss those results at 5:00 p.m. (Eastern Time) that day. There will be a question-and-answer session following prepared remarks from the Company.

To ensure that you are on the call when it begins, we suggest that you access the call approximately 5 to 10 minutes prior to the scheduled start time.
       

Date:
       

Thursday, March 28, 2013

Start Time:

5:00 p.m. Eastern Time

(4:00 p.m. Central Time)

U.S. Dial-In Number:

1-888-679-8018

Outside U.S. Dial-In Number:

617-213-4845

Passcode:

64188515

Conference Call Host:

Brian Keogh

The conference call will be replayed for one week, starting approximately one hour after the call ends. For callers within the United States, the replay number is 1-888-286-8010. For callers outside the United States, the replay number is 617-801-6888. The passcode for both of these numbers is 82473229 .

A live webcast and replay of the conference call also will be available on the company website at www.KipsBayMedical.com. If you have any questions, please call Investor Relations at Kips Bay Medical, Inc. at 763-235-3540.

About Kips Bay Medical

Kips Bay Medical, Inc., founded in 2007 and headquartered in Minneapolis, Minnesota, is a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, or eSVS MESH, for use in coronary artery bypass grafting surgery. The eSVS MESH is a nitinol mesh sleeve that, when placed over a saphenous vein graft during CABG surgery, is designed to improve the structural characteristics and long-term performance of the saphenous vein graft. Additional information about Kips Bay Medical, Inc. can be found at www.KipsBayMedical.com.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,131.84 -242.92 -1.48%
S&P 500 1,925.30 -25.83 -1.32%
NASDAQ 4,693.3540 -40.1430 -0.85%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs